Boryung-Astellas co-promote ‘Harnal D’ & ‘Vesicare’
Boryung Pharm and Astellas Pharma Korea will start the co-promotion business for the dysuria symptom enhancer “Harnal D’ and the overactive bladder symptom therapy ‘Vesicare.’
Boryung Pharm(CEO Tae-Hong Choi) and Astellas Pharma Korea(President Hae-Do Jung) signed a co-promotion agreement of ‘Ha...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
